Objectives: To investigate the hypothesis that persistence of apical contraction into diastole is linked to reduced myocardial perfusion and chest pain.
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Introduction
Hypertrophic cardiomyopathy (HCM) is characterised by marked left ventricular (LV) hypertrophy (LVH) [1] . Patients frequently experience troubling chest pain [2] [3] [4] [5] .
Several studies demonstrate myocardial perfusion abnormalities in HCM [6] [7] [8] [9] [10] and others describe biochemical evidence for myocardial ischaemia [11, 12] . In the absence of coronary disease or LV outflow obstruction, microvascular disease is often assumed to be the cause of myocardial ischaemia. This assumption is based on a few studies that report structural abnormalities of the microvasculature [13] [14] [15] [16] .
Notably, limited data associates structural changes with perfusion abnormalities or chest pain [15, 17] .
Myocardial perfusion occurs almost exclusively in diastole and perfusion pressure is greatest in early diastole when suction force due to decompression of the myocardial microcirculation also augments flow [18] . We hypothesised that regional prolongation of systolic contractility into early diastole is associated with reduced myocardial perfusion in HCM.
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Methods

Study Design
This is a retrospective, cross-sectional, observational cohort study based at the London Chest Hospital, UK. Consecutive cases (age ≥16 years) of apical HCM (August 2008-February 2013) were identified from the registry of a regional CMR centre where adenosine stress perfusion imaging was routinely performed in HCM.
We also studied control cohorts.
Apical HCM Cohort
Morphologic criteria for apical HCM included a maximal end-diastolic LV wall thickness (MWT) ≥15 mm in the apical segments of the heart [1] . We excluded cases where basal septal exceeded apical wall thickness and individuals with left bundle branch block, atrial fibrillation or obstructive coronary disease (>50% narrowing in a major epicardial artery or previous revascularisation). Treated hypertension was not excluded [19] . 237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295   6 
Control Cohorts
We identified two control groups: a). Consecutive patients with the asymmetric septal hypertrophy (ASH) variant of HCM who had also undergone perfusion CMR imaging (control-HCM). b). Normal controls identified through a low-intermediate risk chest pain pathway in whom coronary angiography and perfusion CMR were performed as part of a prospective research study comparing the diagnostic accuracies of these modalities (EVINCI: NCT00979199) [20] . All normal controls had angiographically normal coronary arteries and structurally normal hearts.
Collection of Clinical Data
Demographic and symptomatic data were collected from electronic records. Chest pain was recorded as present or absent from preceding outpatient clinic letters or scan indication information. Missing data are reported.
Consent and Ethical Approval
This study complies with the declaration of Helsinki and was conducted as audit (Clinical Management of the Inherited and Acquired Heart Muscle Diseases, BartsHealth NHS Trust audit No. 5298). As per protocol, ethics committee approval and informed consent were not sought. 
CMR Image Acquisitions and Analysis
All studies were performed on a 1.5 T magnet (Achieva®, Philips Medical Systems) and images acquired using standard protocols, medication was not withheld prior to imaging. Briefly, balanced steady-state free precession cine (SSFP) images were acquired with 25-30 phases/cardiac cycle (8mm slice thickness, 2mm gap for short axis (SAX) images; typical voxel size 1.9 x 1.9 mm). For perfusion imaging, gadolinium based contrast bolus (Dotarem®) was followed by saline flush. SAX images at basal, mid and apical LV level were obtained at peak stress (adenosine 140 μg/Kg/min, 4 minutes) and at rest. For late gadolinium enhancement (LGE), T1 weighted inversion-recovery gradient echo images were acquired approximately 10 min after gadolinium (typical voxel 2.07 x 2.16 mm, slice thickness 8 mm, FOV 300 mm).
LV Dimensions and Mass
Endocardial and epicardial borders, including papillary muscles and trabeculae (PMT) within blood pool, were manually traced on SAX images in all cardiac phases (Extended MR Workspace ® , Philips Medical Systems). Ejection fraction (EF), stroke volume (SV) and LV mass were calculated. Regional (SAX) LV volume was calculated (epicardial -endocardial volume). or diastole (%D) during which obliteration was present.
Perfusion Analysis
The myocardial perfusion reserve index (MPRi) was calculated in basal, mid and apical SAX slices that were not separated into American Heart Association (AHA) segments (without segmentation) [21, 22] . Epicardial, endocardial and blood pool contours were manually traced. After baseline correction, stress and rest signal intensity (SI) time curves were constructed. Maximum upslope was measured using a 4-point window for the myocardium and a 2-point window for the blood pool and mean myocardial maximum upslope was obtained for basal, mid and apical SAX slices, and corrected for arterial input [23] . MPRi was calculated by dividing stress by rest values .   414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472 
Late Gadolinium Enhancement
Quantity of LGE on T1 weighted images was determined using the full-width half max (FWHM) technique (CMR42, Circle Cardiovascular Imaging Inc., Canada) [24, 25] . The FWHM method was applied to the three SAX slices co-localizing with basal, mid and apex perfusion images and LGE was expressed, without segmentation, as %myocardium.
Intra-and Inter-observer Error
For intra-observer error, MPRi was measured in a random sample of 10 apical HCM twice (with a gap of 1 week), in a random order. For inter-observer error, two independent measurements of MPRi were made in 5 scans, in a random order, by two observers. All patient-identifiable information was removed from the scans and the observers blinded to all other results.
Statistical Analysis
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Results
CMR images of sufficient quality were available from 126 subjects (76 apical HCM, 31 ASH-controls and 19 normal controls). The baseline characteristics of the cohort are shown in Table 1 .
Global and Regional LV Morphological Characteristics
Apical-HCM and control-HCM patients had similar LV end-diastolic and end-systolic volumes (EDV and ESV), LV mass and MWT. EF was marginally greater in apical HCM.
There were differences in regional morphology; apical and mid-LV end-diastolic cavity volumes were lower in apical than in control-HCM but similar at the base.
The myocardial volume in the apical SAX slices was greater in apical HCM than control-HCM, but similar in the basal and mid-LV. These data are shown in Table 2 .
Resting LV outflow tract obstruction was present in 12 (39%) control-HCM patients.
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LV Cavity Obliteration
No normal controls demonstrated LV obliteration; the threshold for cavity obliteration was lower than end-systolic apical endocardial area in normal controls (3.3±1.4 cm 2 ) by 2.2 standard deviations (98 th percentile).
In apical HCM, LV cavity obliteration was detected in the apex, mid and basal LV in 79%, 32% and 3% respectively, and in 39%, 13% and 0% of control-HCM (χ 2 p<0.001 for apex, p=0.03 for mid).
In apical HCM, LV cavity obliteration persisting into diastole was demonstrated in apical, mid and basal LV regions in 78%, 26% and 3% respectively, and in 26%, 13% and 0% of control-HCM (χ 2 p<0.001 for apex).
Cavity obliteration was present for median 32%CC in the apex (interquartile range 13%-43%) and 0%CC in the mid (0-9%) in apical HCM; and for 8%CC (0-13%) and 0%CC (0-0%), respectively, in control-HCM (p<0.001 for apex, p<0.05 for mid).
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Regional Myocardial Perfusion
MPRi at the apex in apical HCM (1.1±0.3) was lower than that in control-HCM (1.5±0.6; p<0.001) and normal controls (1.6±0.5; p<0.001). MPRi in the basal and mid LV were similar in apical and control-HCM groups (Table 2) . In apical HCM, MPRi was lower in the apex than the base (1.1±0.3 and 1.3±0.4 respectively; p<0.001). MPRi was also lower, in apical HCM, at the apex compared to the mid-LV (1.1±0.3 and 1.2±0.5 respectively; p=0.03). MPRi at all three levels were similar in control-HCM and in normal controls.
Global and Regional Late Gadolinium Enhancement
Globally, %LGE in apical and control-HCM was similar. Regionally, in apical HCM, %LGE in the apex (7.3±8.0%) was greater than in the base (4.7±5.7%, p=0.007) and greater than in the apex of control-HCM (1.9±3.7%; p=0.002). There was a significant univariate association between %LGE and MWT in the apex of apical HCM (ρ=0.40, p<0.001).
Apical HCM
Chest Pain and Myocardial Perfusion
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Magnitude of LVH
MWT tertiles had similar chest pain prevalence and regional apical MPRi (Table 3) . %LGE was greatest in the highest MWT tertile; for all patients, there was a significant univariate correlation between MWT and %LGE (r=0.36, p=0.001), but not with MPRi (Table 4) .
Duration of Apical Cavity Obliteration
Apical obliteration persisted through a median of 50%D (interquartile range 44%-55%) in the group with most obliteration (CIII), 33%D (29-37%) and 0%D (0-12%) in intermediate (CII) and least severe groups (CI) respectively. Most measures of global LV structure/function and %LGE were similar.
Chest pain was much more frequently reported in CIII (χ2 p<0.05; Table 3 ). Apical MPRi was lower in CIII patients than CI (p<0.001) and CII (p=0.007). For all apical HCM, both %D (r=-0.52, r 2 =0.27, p<0.001) and %CC (r=-0.54, r 2 =0.29, p<0.001) correlated with MPRi (Table 4, Figure 2A ).
Multivariate Analyses
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Inter-and Intra-observer Error
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Discussion
This study shows for the first time that chest pain in apical HCM is associated with distinct contractile abnormalities. Our novel finding is that the persistence of apical contraction is strongly associated with chest pain and regional impairment in myocardial perfusion. We suggest that apical muscle exhibits pathological contractility into diastole, resulting in ischaemia and symptoms.
In comparison to other morphologic variants, apical HCM has a relatively benign prognosis in both Western and Asian populations [26, 27] . Reported prevalence of chest pain in patients with apical HCM cared for at tertiary centres varies widely between 30 and 92% and is frequently refractory to pharmacological therapy [26] [27] [28] [29] [30] [31] [32] .
Chest pain is commonly attributed to myocardial ischaemia, the cause of which is not well understood and several mechanisms including microvascular dysfunction, reduced capillary density and myocardial bridging have been implicated [33] [34] [35] .
Early diastole is particularly important for myocardial perfusion [18] . We hypothesised that regional differences in persistence of early diastolic contractility could result in impaired myocardial perfusion in HCM. In order to examine this hypothesis, we used CMR to assess regional contractility and MPRi in apical HCM and used two comparator cohorts to investigate morphologic and contractile abnormalities particular to apical HCM. Notably, despite similar disease severity (including LV mass, max wall thickness and %LGE), LV cavity obliteration, a common feature of apical HCM, was considerably less frequently detected in ASH-HCM, and was much less persistent when present. Cavity obliteration was not detected in normal controls. 886  887  888  889  890  891  892  893  894  895  896  897  898  899  900  901  902  903  904  905  906  907  908  909  910  911  912  913  914  915  916  917  918  919  920  921  922  923  924  925  926  927  928  929  930  931  932  933  934  935  936  937  938  939  940  941  942  943  944 The pathophysiology of chest pain in HCM is complex. In this study of apical HCM, almost all patients with contractile systolic persistence of >40% of cardiac cycle and/or MPRi<1 experienced chest pain ( Figure 2B ). However, chest pain was also present in the absence of these two abnormalities in a substantial subgroup of patients, suggesting that other factors are contributing. Similarly, low MPRi is not always associated with contractile systolic persistence of >40%, suggesting that additional factors are at play [6, [36] [37] [38] .
Implications for other HCM Variants
In apical HCM, cavity obliteration is easily detectable and quantifiable. Post-systolic regional contractile persistence in other variants/myocardial regions may be less readily discerned. For example, in patients with ASH, an AHA-segmental rather than regional analysis of LV contraction would be required to demonstrate this phenomenon in the basal septum. Analyses of differences in regional strain may help determine if this mechanism contributes to symptoms in other HCM variants, and in other cardiac conditions .   945  946  947  948  949  950  951  952  953  954  955  956  957  958  959  960  961  962  963  964  965  966  967  968  969  970  971  972  973  974  975  976  977  978  979  980  981  982  983  984  985  986  987  988  989  990  991  992  993  994  995  996  997  998  999  1000  1001  1002  1003 
Therapeutic Implications
Our hypothesis is consistent with the efficacy of conventional drug therapies for symptomatic HCM that decrease contractility, prolong diastole and promote lusitropy.
For drug-refractory chest pain, invasive options are only considered when there is dynamic LV obstruction [1] ; such symptoms can be exceptionally difficult to manage in non-obstructive HCM. We present very preliminary evidence that therapies which manipulate contraction/relaxation on a global (with investigative molecules such as MYK-461/Mavacamten) or a regional basis (such as RV or LV pacing) may warrant further investigation in severely symptomatic apical HCM [31, 39, 40] . These investigations should be advanced in rigorous peer-reviewed prospective research settings. Notably, the regional reduction of muscle mass (surgical and non-surgical myectomy) that has been advocated for some patients with severe forms of apical HCM may, in part, improve chest pain by interrupting this mechanism [30, 41] .
Limitations
This single centre study retrospectively selects HCM patients that have undergone stress CMR. Stress CMR imaging is a routine component of our clinical evaluation of all HCM patients in the absence of contra-indications. In addition, several subjects scanned in our centre are managed in other centres, limiting available data and contributing to selection bias. This also meant we were unable to index our CMR findings to body surface area. There was a non-significant trend for apical HCM patients with more severe disease, in terms of apical contractile persistence, to be more likely to be treated with a beta-blocker and/or calcium channel antagonist.
Differences in medical therapy may have affected LV contraction, but these are more likely to obscure a relationship between contractility and symptoms.
A prospective study would include long-axis perfusion imaging to account for longaxis systolic function, as well as more specialised quantitative perfusion techniques (for example by using a dual-bolus approach to assess myocardial blood flow (MBF)). Tissue tagging could provide additional data on regional differences in contraction and relaxation. Finally, hypercontractility would be assessed on images obtained during stress. A prospective study could also include invasive perfusion pressure and volume measurements to further substantiate our observations.
Conclusions
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